Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Clinical Pharmacology and Therapeutics
|
September 9, 2024
Partial Residual Plots as an Integrated Model Diagnostic Tool in Model-Based Meta-Analysis
John Maringwa, Paul Matthias Diderichsen, Chandni Valiathan
DNA Repair
|
December 3, 2011
A rapid survival assay to measure drug-induced cytotoxicity and cell cycle effects
Chandni Valiathan, Jose L McFaline, Leona D Samson
The Journal of Pharmacy and Pharmacology
|
September 28, 2016
Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir
Rajesh Krishna, Lilly East, Patrick Larson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 5, 2026
MBMA Bridging Models as a Tool for Exploration of Clinical Endpoints in Unstudied Indications
Mehrdad Javidi, Gregory E Alexander, Teddy Kosoglou, et al.
American Journal of Clinical Oncology
|
September 11, 2019
Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible
Tomoko Freshwater, Haojie Li, Chandni Valiathan, et al.
NPJ Vaccines
|
November 5, 2021
A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data
Julie Dudášová, Regina Laube, Chandni Valiathan, et al.
Biopharmaceutics & Drug Disposition
|
October 4, 2016
Atazanavir increases the plasma concentrations of 1200 mg raltegravir dose
Rajesh Krishna, Lilly East, Patrick Larson, et al.
Genes & Development
|
September 23, 2008
Genomic predictors of interindividual differences in response to DNA damaging agents
Rebecca C Fry, J Peter Svensson, Chandni Valiathan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 16, 2023
Model-based meta-analysis of non-small cell lung cancer with standard of care PD-1 inhibitors and chemotherapy for early development decision making
David C Turner, Russ Wada, Helen Zhou, et al.
Plos Genetics
|
November 28, 2007
Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers
Rebecca C Fry, Panida Navasumrit, Chandni Valiathan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Clinical Pharmacology and Therapeutics
|
September 9, 2024
Partial Residual Plots as an Integrated Model Diagnostic Tool in Model-Based Meta-Analysis
John Maringwa, Paul Matthias Diderichsen, Chandni Valiathan
DNA Repair
|
December 3, 2011
A rapid survival assay to measure drug-induced cytotoxicity and cell cycle effects
Chandni Valiathan, Jose L McFaline, Leona D Samson
The Journal of Pharmacy and Pharmacology
|
September 28, 2016
Effect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravir
Rajesh Krishna, Lilly East, Patrick Larson, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 5, 2026
MBMA Bridging Models as a Tool for Exploration of Clinical Endpoints in Unstudied Indications
Mehrdad Javidi, Gregory E Alexander, Teddy Kosoglou, et al.
American Journal of Clinical Oncology
|
September 11, 2019
Systematic Literature Review and Meta-Analysis of Response to First-Line Therapies for Advanced/Metastatic Urothelial Cancer Patients Who Are Cisplatin Ineligible
Tomoko Freshwater, Haojie Li, Chandni Valiathan, et al.
NPJ Vaccines
|
November 5, 2021
A method to estimate probability of disease and vaccine efficacy from clinical trial immunogenicity data
Julie Dudášová, Regina Laube, Chandni Valiathan, et al.
Biopharmaceutics & Drug Disposition
|
October 4, 2016
Atazanavir increases the plasma concentrations of 1200 mg raltegravir dose
Rajesh Krishna, Lilly East, Patrick Larson, et al.
Genes & Development
|
September 23, 2008
Genomic predictors of interindividual differences in response to DNA damaging agents
Rebecca C Fry, J Peter Svensson, Chandni Valiathan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 16, 2023
Model-based meta-analysis of non-small cell lung cancer with standard of care PD-1 inhibitors and chemotherapy for early development decision making
David C Turner, Russ Wada, Helen Zhou, et al.
Plos Genetics
|
November 28, 2007
Activation of inflammation/NF-kappaB signaling in infants born to arsenic-exposed mothers
Rebecca C Fry, Panida Navasumrit, Chandni Valiathan, et al.
Page
of 2